In animal models, one study found that rats (both obesity-prone and obesity-resistant rats) increased their intake of high fat food, while, decreasing their intake of “regular” food after receiving bromocriptine (a dopamine, DRD2, agonist). This evidence concerns the gene DRD2 and obesity disorder.